A compound found in pomegranates, berries, and sumac activates PI3K-Akt signaling — the same cellular growth pathway that drives prostate cancer progression. This finding challenges the common assumption that antioxidant-rich foods are universally beneficial during cancer treatment, particularly for patients taking bicalutamide.
Key Findings
• Ellagic acid in sumac and moringa activates PI3K-Akt signaling [1], a pathway that promotes cancer cell survival and growth • Baicalein from grape leaves inhibits estrogen signaling [4], potentially beneficial since some prostate cancers respond to hormonal pathways • Galangin in galangal blocks both PI3K-Akt [11] and MAPK signaling [12], two key cancer growth pathways • Bicalutamide inhibits CYP2D6, creating potential interactions with berberine and other plant compounds that also affect this enzyme
Molecular Pathway
Why Nutrition Matters for Prostate Cancer and Bicalutamide
Prostate cancer cells depend heavily on growth signals to survive and spread. The androgen receptor (AR) — mutated in nearly all prostate cancers — normally responds to testosterone. Bicalutamide blocks this receptor, starving cancer cells of their primary growth signal.
However, cancer cells adapt by hijacking backup growth pathways. PI3K-Akt signaling tells cells to grow and resist death. MAPK pathways relay proliferation signals. When TP53 (the "guardian of the genome") is mutated — as it is in 25% of prostate cancers — these backup systems become even more important for cancer survival.
The foods you eat contain compounds that can either support or undermine your treatment. Some activate the very pathways bicalutamide is trying to shut down. Others reinforce your therapy by blocking additional growth signals.
Molecular Pathway
The Growth Signal Activators
Sumac and Moringa: The Ellagic Acid Concern
Both sumac and moringa contain ellagic acid, a compound that activates PI3K-Akt signaling [1]. This pathway acts like a cellular accelerator, telling cells to grow, divide, and resist programmed death. In healthy cells, this helps with tissue repair. In cancer cells, it provides survival signals that work against your treatment.
The same compound also strengthens tight junctions [2] — the connections between cells. While this might sound protective, cancer cells can exploit stronger cell-to-cell connections to form more cohesive tumors and resist treatment.
These findings come from studies on depression and neurodegeneration, not cancer specifically. However, PI3K-Akt signaling works similarly across cell types. Given that this pathway is already overactive in many prostate cancers, foods that further stimulate it warrant caution.
Compounds That Block Cancer Pathways
Grape Leaves: Dual Pathway Inhibition
Grape leaves contain baicalein, a flavonoid that targets two important cancer pathways. It inhibits thyroid cancer progression by blocking the TPL2/MEK2/ERK2 pathway [3] — a chain reaction that normally promotes cell division. More relevant to prostate cancer, baicalein also inhibits estrogen signaling [4].
While prostate cancer is primarily driven by androgens like testosterone, some advanced prostate cancers develop sensitivity to estrogen pathways as well. By blocking these signals, baicalein may complement bicalutamide's anti-androgen effects.
Grape leaves can be found fresh at Middle Eastern markets or dried as tea. Add fresh leaves to salads or steep dried leaves for 10 minutes to make tea.
Galangal: Comprehensive Growth Signal Blockade
Galangal, a ginger-like root common in Thai cooking, contains galangin — a compound with dual anti-cancer mechanisms. It inhibits PI3K-Akt signaling [11], directly opposing the growth signals that cancer cells need to survive. It also blocks MAPK pathways [12], which relay proliferation commands from the cell surface to the nucleus.
This dual action makes galangin particularly interesting for prostate cancer, where multiple growth pathways often work together. The compound specifically targets epithelial-to-mesenchymal transition — the process by which cancer cells become more invasive and able to spread.
Fresh galangal can be grated into curries and stir-fries, or dried galangal powder can be added to soups and marinades.
Foods to Approach with Caution
Bergamot: Mixed Signals
Bergamot contains carvacrol, which presents a complex profile. It inhibits colorectal cancer by regulating gut bacteria [7] and promotes cell death in breast cancer cells [8]. However, the mechanism in breast cancer involves the PI3K-Akt pathway — the same growth signal that's problematic in prostate cancer.
The gut microbiome effects might be beneficial, but the direct cellular effects are unclear for prostate cancer. Given the uncertainty, bergamot oil or supplements should be used cautiously during bicalutamide treatment.
Blackberry: The Acetaldehyde Problem
Blackberries naturally contain acetaldehyde, a compound with concerning effects on immune surveillance. It impairs cGAS activity [9], weakening the cellular alarm system that detects cancer DNA. It also activates genes that produce matrix metalloproteinase-9 [10], an enzyme that helps cancer cells break through tissue barriers and spread.
These effects directly undermine two of your body's natural cancer defenses: immune recognition and tissue integrity. Fresh blackberries in moderation are likely fine, but concentrated blackberry extracts or supplements should be avoided.
Drug Interactions Through CYP2D6
Bicalutamide inhibits CYP2D6, an enzyme that processes many medications. This creates potential interactions with plant compounds that also affect this enzyme. Berberine, found in goldenseal and barberry, both inhibits CYP2D6 and is processed by it — creating a complex interaction that could alter both the herb's effects and bicalutamide's metabolism.
If you take other medications processed by CYP2D6 — including some antidepressants, heart medications, or pain relievers — discuss any herbal supplements with your oncologist before starting them.
Want recommendations personalized to your exact diagnosis?
addon scores every food and supplement against your specific cancer type, treatment regimen, and genetic mutations - backed by the same evidence you see in this article.
Get your free preview